Related by context. All words. (Click for frequent words.) 70 APTIVUS r 69 IFN beta 69 EXJADE 68 HER2 expression 68 trastuzumab Herceptin ® 68 renal toxicity 67 plasma pharmacokinetics 67 riociguat 67 nephrotoxicity 67 intravenous bisphosphonates 67 hyperalgesia 67 canakinumab 67 EBV infection 67 efalizumab 67 transaminase elevations 67 corticosteroid therapy 66 KRAS status 66 inotropic 66 CANCIDAS 66 HIV HCV coinfected 66 INVEGA ® 66 paricalcitol 66 ALT flares 66 AST ALT 66 anthracycline chemotherapy 66 virological response 66 platelet reactivity 66 HBeAg seroconversion 66 SCIg 66 serum antibody 66 chlamydial infection 65 Natalizumab 65 GSK# [001] 65 EGFRIs 65 dosage regimens 65 HBsAg 65 busulfan 65 hyperprolactinemia 65 GnRH agonists 65 mycophenolate mofetil 65 adrenal suppression 65 β blocker 65 ziconotide 65 interferon therapy 65 T#I [002] 65 EGFR TKI 65 CIMZIA ™ 65 myopathy rhabdomyolysis 65 hematologic toxicity 65 antiangiogenic therapy 65 B7 H3 65 Pseudomonas aeruginosa infections 65 cardiac toxicity 65 alteplase 65 antibody titer 65 mesalamine granules 65 Telintra 65 epithelial tumors 65 pentoxifylline 65 IV bisphosphonates 65 IgM antibodies 65 solifenacin 65 genotypic resistance 64 VAPRISOL 64 colorectal liver metastases 64 TNF antagonist 64 recurrent glioblastoma multiforme 64 aminotransferases 64 virologic failure 64 severe hypersensitivity reactions 64 anti JCV antibodies 64 MYCAMINE 64 GAMMAGARD 64 gadobutrol 64 ADPKD 64 lupus anticoagulant 64 antimuscarinic 64 SLNB 64 antiphospholipid antibodies 64 latent tuberculosis infection 64 analgesic medications 64 acute GvHD 64 serum antibodies 64 d dimer 64 CMV infection 64 symptom exacerbation 64 mepolizumab 64 histological subtype 64 hematological toxicity 64 Traficet EN 64 H pylori 64 β blockers 64 anti HBs 64 macrolide antibiotic 64 antioxidant supplementation 64 fosamprenavir 64 TMP SMX 64 rhGH 64 orchitis 64 metastatic lymph nodes 64 HCV antibody 64 HPA axis suppression 64 serum concentrations 64 OAB symptoms 64 FXIII 64 androgen suppression 64 surrogate endpoint 64 p# activation 64 coinfected patients 64 oral FTY# 64 apneic episodes 64 metastatic neuroendocrine tumors 64 tumoral 64 immunosuppressive agents 64 endotoxemia 64 HER2 overexpression 64 gemifloxacin 64 MAGE A3 ASCI 64 thyroglobulin 64 immunological responses 64 antimicrobial prophylaxis 64 serum calcium levels 64 lymphopenia 64 eosinophil count 64 pyridostigmine 64 tumor histology 64 BENICAR HCT 63 TEAEs 63 dopaminergic therapy 63 haematologic 63 intravascular hemolysis 63 airway responsiveness 63 LHRH agonists 63 K ras mutations 63 antidepressant efficacy 63 eculizumab therapy 63 LTBI 63 IgG4 63 MGd 63 AGILECT R 63 IL 1ß 63 elevated IOP 63 isoproterenol 63 Decitabine 63 chlamydial 63 gastric adenocarcinoma 63 ZOLINZA 63 neutropaenia 63 mg kg dose 63 PSA nadir 63 neutropenic patients 63 ELISPOT 63 PASI scores 63 hypocalcemia 63 APTIVUS 63 carcinoids 63 HAART regimens 63 tipranavir ritonavir 63 concomitant medications 63 octreotide LAR 63 peginterferon 63 hematological parameters 63 tegaserod 63 pharmacokinetic interactions 63 HBeAg negative 63 neuropsychiatric symptoms 63 coronary stenoses 63 advanced adenomas 63 ovarian carcinoma 63 extrapyramidal symptoms EPS 63 immunosuppressive therapies 63 lactate dehydrogenase 63 cytopenias 63 MGUS 63 hemorrhagic cystitis 63 BRAF V#E mutation 63 antiandrogens 63 tranylcypromine 63 hypersensitivity reaction 63 parasitemia 63 VA# [002] 63 L lysine 63 ACTEMRA TM 63 CIMZIA TM certolizumab pegol 63 superficial bladder cancer 63 steroid dexamethasone 63 imatinib therapy 63 bezafibrate 63 oral anticoagulation 63 IGFBP 3 63 ATACAND 63 KETEK 63 liposomal amphotericin B 63 immunosuppressant therapy 63 cardiac troponin 63 serum urate levels 63 lenalidomide dexamethasone 63 teriflunomide 63 Kinoid 63 PROCHYMAL 63 pharmacodynamic parameters 63 dose proportionality 63 florbetaben 63 renal cysts 63 liver histology 63 specific antigen PSA 63 APTIVUS ritonavir 63 oxcarbazepine 63 axillary node 63 tipranavir 63 gastrointestinal stromal tumors GIST 63 CYP #A# 63 vismodegib 63 SGPT 63 PNH patients 62 virologic responses 62 DOXIL 62 ursodeoxycholic acid 62 therapeutic regimens 62 QTc prolongation 62 S. aureus isolates 62 clobazam 62 BCR ABL mutations 62 neurologic complications 62 EGFR inhibitors 62 hepatitis C genotype 62 antiviral efficacy 62 needleless connectors 62 skeletal metastases 62 imatinib resistance 62 fluoroquinolone resistance 62 NPM1 mutation 62 treprostinil 62 potentiation 62 Gag polymorphisms 62 demyelinating 62 candidemia 62 COPD exacerbations 62 PegIFN RBV 62 antibody titers 62 timepoints 62 ribavirin therapy 62 salmeterol fluticasone 62 Symadex 62 thromboprophylaxis 62 posttransplant 62 hypercalcemia 62 serum IgG 62 intravitreal injections 62 delayed CINV 62 Kepivance 62 mycophenolate mofetil MMF 62 adrenalectomy 62 relapsed MM 62 dysmenorrhoea 62 Octreolin 62 adrenal cortex 62 ibandronate 62 thromboembolic complications 62 prucalopride 62 grade cervical intraepithelial 62 adrenal function 62 nephrotoxic 62 chloride secretion 62 Hypotension 62 HBeAg positive patients 62 acetylcysteine 62 virologic response 62 aldosterone antagonist 62 dexrazoxane 62 micafungin 62 cTnI 62 mcg BID 62 complete cytogenetic response 62 BRAF mutation 62 serum cortisol 62 upper gastrointestinal bleeding 62 Known hypersensitivity 62 elevated ALT 62 HAV infection 62 fulvestrant 62 tipranavir r 62 methylprednisolone 62 ACZ# 62 Vimpat R 62 serologic testing 62 Index CDAI 62 pharmacodynamic effects 62 immunocompetent 62 saline placebo 62 BAL# [002] 62 divalproex sodium 62 Candida infection 62 sulfasalazine 62 INTELENCE 62 urine cytology 62 lichen planus 62 ALT normalization 62 intensive statin therapy 62 CIN3 62 4CMenB 62 mitomycin C 62 DACH platinum 62 PREZISTA r 62 methotrexate therapy 62 aromatase inhibitor therapy 62 KRAS mutation 62 calcineurin inhibitors 62 invasive candidiasis 62 DFMO 62 caspofungin 62 tigecycline 62 Immunohistochemical analysis 62 Arikace 62 intraventricular 62 preoperative chemotherapy 62 tolvaptan 62 phototoxicity 62 acid suppressive therapy 62 sonographic diagnosis 62 LEXIVA r 62 corticosteroid dose 62 HBeAg 62 acromegalic patients 62 BoNTA 62 hepatic enzymes 62 radioiodine therapy 62 rhTSH 62 serum phosphorous 62 bronchoalveolar lavage 62 serum phosphate levels 62 dual endothelin receptor antagonist 62 abacavir Ziagen 62 hyperphenylalaninemia HPA due 62 systemic corticosteroid 62 lymphocytosis 62 symptomatic VTE 62 tumor lysis syndrome 62 certolizumab 62 hepatic function 62 serum phosphate 62 proliferative diabetic retinopathy 62 lipohypertrophy 62 thiopurine 62 immunomodulation 62 hemolytic 62 calcitriol 62 leucopenia 62 antibiotic prophylaxis 62 Non inferiority 62 adalimumab 62 node metastases 62 intra articular injection 62 nitrofurantoin 62 extrapyramidal symptoms 62 postoperative morbidity 62 reactogenicity 62 IgG antibodies 62 bovine thrombin 62 Heavy menstrual bleeding 62 triamcinolone 62 Vaprisol 62 coronary stenosis 62 thrombotic complications 62 IFN γ 62 immunomodulatory therapy 62 HbA 1c levels 62 sputum cultures 62 protease inhibitor PI 62 posaconazole 62 CYP#D# inhibitors 62 avosentan 62 alanine aminotransferase ALT 62 serum aminotransferase levels 62 invasive aspergillosis 62 leukocytosis 62 severe exacerbations 62 adrenocorticotropic hormone 62 perioperatively 61 hypereosinophilic syndrome 61 rFVIIa 61 somatostatin analogs 61 thyrotropin 61 NATRECOR ® 61 hypomagnesemia 61 IFN α 61 guanfacine 61 antiarrhythmic drugs 61 rtPA 61 Cardiotoxicity 61 STRIDE PD 61 serum IgE 61 RAS blockers 61 androgen deprivation 61 macroalbuminuria 61 Dasatinib 61 systemic toxicity 61 TPMT 61 primary aldosteronism 61 cTnT 61 Xanafide 61 neurologic symptoms 61 intradermal injection 61 favorable pharmacokinetic profile 61 heterozygous FH 61 FluCAM arm 61 undetectable HBV DNA 61 TNFalpha 61 sustained virological response 61 lamotrigine 61 mu opioid 61 NMDA receptor antagonists 61 #mg dose [002] 61 metastatic malignant melanoma 61 scintigraphic 61 HbF 61 clomipramine 61 posttreatment 61 rilonacept 61 varicella infection 61 alefacept 61 prolonged QT interval 61 flavopiridol 61 ritonavir boosted 61 hemoglobin Hb 61 vasodilators 61 NSAID therapy 61 IgM 61 allogeneic HSCT 61 hyperacute 61 pheochromocytoma 61 bacterial prostatitis 61 interleukin IL -# 61 virological suppression 61 CIMZIA TM 61 systemic corticosteroids 61 AA Amyloidosis 61 POAG 61 salivary flow 61 Akt activation 61 pretest probability 61 tuberculin test 61 herpes zoster vaccine 61 artery stenosis 61 antiemetics 61 octreotide 61 probiotic supplementation 61 hematologic parameters 61 indinavir 61 pharmacodynamic PD 61 immunocompetent patients 61 clinically detectable 61 carcinoid tumors 61 anti HBc 61 BARACLUDE ® 61 hemorrhagic complications 61 antitumor effect 61 Aggrastat ® tirofiban hydrochloride 61 lipid parameters 61 eosinophilic asthma 61 FOLPI 61 asthma exacerbations 61 hepatic toxicity 61 Severe Primary IGFD 61 clevidipine 61 N. gonorrhoeae 61 null responder 61 prodromal symptoms 61 splenectomized patients 61 neuroleptics 61 XmAb# 61 inhaled glucocorticoids 61 CSF biomarkers 61 recurrent VTE 61 hypotensive 61 LVNC 61 NUCYNTA R 61 relapsed AML 61 HBeAg negative patients 61 C1 INH 61 PROMACTA 61 androgen ablation 61 Thrombocytopenia 61 INFERGEN 61 anemia hemoglobin 61 #mg BID [001] 61 Hematologic 61 bone scintigraphy 61 endometrial hyperplasia 61 HAART regimen 61 hypericin 61 amphotericin B 61 Subgroup analyzes 61 FASLODEX 61 anagrelide 61 virologic breakthrough 61 carotid IMT 61 FOSRENOL ® 61 interferon γ 61 laboratory abnormalities 61 HBV DNA levels 61 vWF 61 QT interval prolongation 61 overt hypothyroidism 61 Cervista HPV HR 61 trimethoprim sulfamethoxazole 61 AMEVIVE 61 serum retinol 61 cardiac troponin T 61 galiximab 61 bacteriuria 61 ovarian hormones 61 varices 61 antiviral therapy 61 intranasal corticosteroid 61 refractory gout 61 neutropenic fever 61 myelosuppression 61 timepoint 61 severe neutropenia 61 histologic subtype 61 IgA antibodies 61 glomerular filtration 61 Teriflunomide 61 carcinoid 61 gonococcal infections 61 unfavorable cytogenetics 61 AZT zidovudine Retrovir 61 EUS FNA 61 relapsed SCLC 61 Oral corticosteroids 61 fluvastatin 61 hypersensitivity allergic reactions 61 nonalcoholic steatohepatitis NASH 61 esophageal candidiasis 61 suppressive therapy 61 forodesine 61 BYSTOLIC 61 aspartate aminotransferase AST 61 vesicoureteral reflux 61 cisplatin chemotherapy 61 alkylating agent 61 dosing frequency 61 anticholinergics 61 NATRECOR R 61 pharmacokinetic characteristics 61 glucocorticoid 61 glucocorticoid therapy 61 icatibant 61 vasogenic edema 61 anthracycline therapy 61 neurocognitive deficits 61 DVT PE 61 erythropoietic 61 Interferon Beta 61 systemic absorption 61 mitochondrial toxicity 61 mucosal healing 61 nelfinavir 61 inducible nitric oxide synthase 61 inecalcitol 61 ARIXTRA 61 cranial irradiation 61 dasatinib 61 transaminase levels 61 amenorrhoea 61 FVIII inhibitors 61 nutlin 3a 61 intracranial hemorrhage ICH 61 arbaclofen 61 voriconazole 61 glycated hemoglobin levels 61 weekly subcutaneous injections 61 intestinal mucosa 61 lymphadenopathy 61 beta interferons 61 opioid analgesia 61 ARCALYST ® 61 elevated creatinine 61 serum calcium 61 betamethasone 61 troponin T 61 IOP lowering 61 tobramycin 61 DaTscan 61 anti androgen 61 erlotinib Tarceva 61 desvenlafaxine succinate 61 basal cell nevus syndrome 61 cervical lymph nodes 61 miglustat 61 DAPT 61 TNF α 61 eosinophilia 61 glatiramer acetate 61 anterior uveitis 61 QT QTc 61 pCR 61 viremia 61 perfusion defects 61 subclinical hypothyroidism 61 S. aureus colonization 60 apremilast 60 plasminogen activators 60 locoregional 60 prostate cancer CaP 60 CYP#C# genotype 60 torsade de pointes 60 Hurthle cell 60 GABHS 60 aldosterone antagonists 60 PHPT 60 hematuria 60 stratifying patients 60 interferon alfa 2b 60 PlGF 60 overactive bladder symptoms 60 NRTI 60 R0 resection 60 intestinal mucosal 60 favorable tolerability 60 systemic hypotension 60 thyrotoxicosis 60 Atopic 60 serum homocysteine 60 INCB# [003] 60 PDE4 inhibitors 60 immune reconstitution 60 COPAXONE ® 60 PRADAXA 60 phenelzine 60 coagulation abnormalities 60 Mantoux test 60 Pharmacokinetic 60 atazanavir 60 cytomegalovirus infection 60 serum HBV DNA 60 thiazide 60 r hGH 60 hydroxychloroquine 60 dose escalation phase 60 YERVOY 60 decitabine 60 CP CPPS 60 ESBLs 60 postoperative complication 60 Leydig cell 60 antihypertensive therapy 60 tryptase 60 IgE mediated 60 methacholine 60 paroxetine Paxil 60 rt PA 60 severe rotavirus gastroenteritis 60 Paliperidone 60 iloprost 60 CIN2 + 60 menopausal symptom 60 virologically 60 overt nephropathy 60 NNRTI resistance 60 KRAS mutations 60 hyperkalemia 60 ertapenem 60 status epilepticus 60 prospectively defined 60 penicillin allergy 60 pyrazinamide 60 oropharyngeal 60 neuroleptic 60 milrinone 60 vitro experiments 60 ACTH 60 GnRH agonist 60 permanently discontinue Vectibix 60 Suicidal ideation 60 CD# upregulation 60 elevated LDH 60 amisulpride 60 carotid stenosis 60 ADAGIO study 60 hematopoietic cancers 60 systemic bioavailability 60 CIPN 60 tumorigenicity 60 IgG antibody 60 OHR/AVR# 60 untreated celiac disease 60 GBM tumors 60 primary hyperparathyroidism 60 AAT deficiency 60 chronicity 60 S. maltophilia 60 ketorolac 60 griseofulvin 60 airway hyperresponsiveness 60 neuropsychological impairments 60 PSA kinetics 60 weekly intravenous infusions 60 cystoscopic 60 EFFEXOR XR 60 anemia thrombocytopenia 60 calcineurin inhibitor 60 colorectal adenoma 60 Bezielle 60 Fingolimod 60 clodronate 60 symptomatology 60 adrenal insufficiency 60 abacavir hypersensitivity 60 varespladib 60 imipenem 60 empiric therapy 60 hematological adverse 60 renal dysfunction 60 serotonin synthesis 60 sodium stibogluconate 60 interferon ribavirin 60 abatacept 60 seropositivity 60 urothelial carcinoma 60 alpha 2a 60 recurrent glioma 60 TNFa 60 azelaic acid 60 axillary lymph node 60 interferon IFN 60 serum potassium 60 chemosensitivity 60 spirometric 60 supine hypertension 60 bolus dose 60 selegiline 60 HuMax EGFr 60 alpha interferons 60 Trastuzumab 60 ximelagatran 60 sustained virologic response 60 antiepileptics 60 intracoronary 60 serologic 60 aminoglycoside 60 Exacerbations 60 renal scarring 60 human chorionic gonadotropin hCG 60 colorectal adenocarcinoma 60 baseline LDH 60 ASCUS 60 hypokalemia 60 dose cohort 60 Helicobacter pylori infection 60 alkylating agents 60 invasive carcinoma 60 acetabular dysplasia 60 HBV vaccine 60 serum lipid levels 60 INVEGA ™ 60 beta lactam antibiotic 60 AChE inhibitors 60 Fluid retention 60 herpesviruses 60 neutrophil counts 60 paraprotein 60 relapsing MS 60 gastrointestinal toxicity 60 BANZEL 60 non hematological toxicities 60 Adjuvant therapy 60 HCV replicon 60 ImmuKnow 60 beta blocker propranolol 60 hip resurfacing arthroplasty 60 P. falciparum malaria 60 ganciclovir 60 peritumoral brain edema 60 CMV disease 60 renal cell carcinomas 60 hematological toxicities 60 EDARBI 60 serum BDNF 60 VADT 60 antithrombotics 60 metastatic malignant 60 Peripheral edema 60 idraparinux 60 Fibrillex TM 60 PREZISTA rtv 60 vidofludimus 60 precancerous cervical lesions 60 metabolic parameters 60 CMV reactivation 60 Pegylated interferon 60 CsA 60 Hepatotoxicity 60 ONTAK 60 antiepileptic medications 60 balsalazide 60 anticancer activity 60 bladder carcinoma 60 dose titration 60 NPH insulin 60 coadministration 60 inhaled budesonide 60 OSAHS 60 knee osteoarthritis OA 60 neutralizing antibody 60 lesional 60 terlipressin 60 thyroid stimulating hormone 60 immunosuppressives 60 pathologic fractures 60 choroidal neovascularization 60 lymphovascular invasion 60 biologic plausibility 60 endometrial biopsy 60 thromboembolic 60 MAGE A3 60 alpha interferon 60 loop diuretics 60 intermittent dosing 60 visilizumab 60 primidone 60 D dimer 60 nucleoside analogues 60 rifamycins 60 CYP#A# inhibitors 60 TroVax ® 60 genital herpes infections 60 #mg/day [001] 60 bactericidal activity 60 mupirocin 60 WNV encephalitis 60 Bosentan 60 EpCAM expression 60 aminotransferase levels 60 clinically meaningful improvement 60 pDCs 60 antitumor efficacy 60 inflammatory biomarkers 60 palifermin 60 intravenous cyclophosphamide 60 KRAS mutant tumors 60 receptor inhibitor 60 psychiatric comorbidities 60 corticosteroid dexamethasone 60 levodopa therapy 60 ENMD # 60 PBMCs 60 estrogen receptor ER 60 anakinra 60 diabetic kidney 60 RLAI 60 prognostic indicator 60 piperacillin tazobactam 60 HBV infections 60 intracranial hypertension 60 granisetron 60 EVIZON 60 ULORIC 60 digoxin toxicity 60 CMV infections 60 cMET 60 radiochemotherapy 60 replicon 60 Adalimumab 60 immunosuppressive regimen 60 serum estradiol 60 thyrotropin levels 60 Lyme arthritis 60 coinfection 60 serum ALT 60 IGRAs 60 atypical antipsychotic medications 60 neurosensory 60 abnormal Pap test 60 serum TSH 60 heparin induced thrombocytopenia 60 nimodipine 60 EUFLEXXA R 60 HPA axis 60 proctitis 60 creatinine levels 60 elevated bilirubin 60 somatostatin analogues 60 clinically meaningful efficacy 60 REMINYL ® 60 interferon alfa 60 QTc 60 carcinoid tumor 60 fibrinolytic 60 cobiprostone 60 oral prodrug 60 neurologic deficits 60 somatic symptoms 60 entecavir 60 pimecrolimus 60 mucosal inflammation 60 gastrointestinal adverse reactions 60 elotuzumab 60 coagulase negative staphylococci 60 TNF inhibitor 60 neutrophil count 60 strontium ranelate 60 Cytoxan 60 advanced adenoma 60 MYLOTARG 60 titrated glipizide 60 potent antiretroviral therapy 60 activated partial thromboplastin 60 GFT# 60 ICD shocks 60 selenium supplementation 60 thromboembolic events 60 ESBA# 60 liver transaminases 60 dobutamine 60 colorectal carcinoma 60 neoadjuvant chemotherapy 60 histologically 60 Telbivudine 60 Doxil ® 60 COPAXONE R 60 Protelos 60 acute HCV infection 60 Mitoxantrone 60 bacteraemia 60 selective modulator 60 sonographically guided 60 antiretroviral naive 59 paragangliomas 59 ovarian malignancy 59 quinolone 59 mucosal lesions 59 alemtuzumab treated 59 hepatitis B infection 59 estrogen hormone therapy 59 osteoblastic 59 juvenile idiopathic arthritis 59 palivizumab 59 pamidronate 59 LATUDA 59 hemodynamically unstable 59 analgesic effects 59 splenic 59 immunosuppressive regimens 59 HBeAg positive 59 Hashimoto thyroiditis 59 serologic tests 59 aT cell 59 pituitary hormone 59 acute bronchospasm 59 systemically administered 59 rFSH 59 malignant ascites 59 Intravenous immunoglobulin 59 bronchogenic carcinoma 59 Bcr Abl mutations 59 miconazole 59 TNF blocker therapy 59 hepatic enzyme 59 peginterferon alfa 59 angiographically 59 rheumatoid factor 59 injected subcutaneously 59 acid suppressive medication 59 urothelial cancer 59 IgE antibody 59 PAOD 59 LNG IUS 59 SPRYCEL ® 59 rHuPH# 59 dexamethasone Decadron 59 HBV DNA 59 serum uric acid 59 immunoreactivity 59 eosinophilic 59 INTEGRILIN R 59 renal allograft 59 Virulizin ® 59 docetaxel Taxotere ® 59 colonic mucosa 59 ULTRAM ER 59 lymphocyte counts 59 IFN gamma 59 nonmelanoma skin cancers 59 cardiotoxic 59 symptom flare ups 59 ToGA 59 NGAL 59 postoperative radiotherapy 59 intravenous diuretics 59 CPAP adherence 59 E. faecalis 59 IBS C 59 corticosteroid 59 Elocalcitol 59 Angioedema 59 AGHD 59 cervicitis